Population risk factors for severe disease and mortality in COVID-19: A global systematic review and meta-analysis

A Booth, AB Reed, S Ponzo, A Yassaee, M Aral… - PloS one, 2021 - journals.plos.org
Aim COVID-19 clinical presentation is heterogeneous, ranging from asymptomatic to severe
cases. While there are a number of early publications relating to risk factors for COVID-19 …

Risk factors for severe and critically ill COVID‐19 patients: a review

Y Gao, M Ding, X Dong, J Zhang, A Kursat Azkur… - Allergy, 2021 - Wiley Online Library
The pandemic of coronavirus disease 2019 (COVID‐19), caused by the severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has caused an unprecedented global …

Demographic risk factors for COVID-19 infection, severity, ICU admission and death: a meta-analysis of 59 studies

BG Pijls, S Jolani, A Atherley, RT Derckx, JIR Dijkstra… - BMJ open, 2021 - bmjopen.bmj.com
Objective We aimed to describe the associations of age and sex with the risk of COVID-19 in
different severity stages ranging from infection to death. Design Systematic review and meta …

Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis

P Malik, U Patel, D Mehta, N Patel, R Kelkar… - BMJ evidence-based …, 2021 - ebm.bmj.com
Objective To evaluate association between biomarkers and outcomes in COVID-19
hospitalised patients. COVID-19 pandemic has been a challenge. Biomarkers have always …

Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery

Y Zhao, Y Shang, W Song, Q Li, H Xie, Q Xu, J Jia… - …, 2020 - thelancet.com
Background The long-term pulmonary function and related physiological characteristics of
COVID-19 survivors have not been studied in depth, thus many aspects are not understood …

Comorbidity and its impact on patients with COVID-19

A Sanyaolu, C Okorie, A Marinkovic, R Patidar… - SN comprehensive …, 2020 - Springer
A novel human coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2), was identified in Wuhan, China, in December 2019. Since then, the virus has made its …

A population-based cohort study of socio-demographic risk factors for COVID-19 deaths in Sweden

S Drefahl, M Wallace, E Mussino, S Aradhya… - Nature …, 2020 - nature.com
As global deaths from COVID-19 continue to rise, the world's governments, institutions, and
agencies are still working toward an understanding of who is most at risk of death. In this …

Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients …

L Palaiodimos, DG Kokkinidis, W Li, D Karamanis… - Metabolism, 2020 - Elsevier
Abstract Background & aims New York is the current epicenter of Coronavirus disease 2019
(COVID-19) pandemic. The underrepresented minorities, where the prevalence of obesity is …

[HTML][HTML] The S1 protein of SARS-CoV-2 crosses the blood–brain barrier in mice

EM Rhea, AF Logsdon, KM Hansen, LM Williams… - Nature …, 2021 - nature.com
It is unclear whether severe acute respiratory syndrome coronavirus 2, which causes
coronavirus disease 2019, can enter the brain. Severe acute respiratory syndrome …

[HTML][HTML] Acute kidney injury in patients hospitalized with COVID-19

JS Hirsch, JH Ng, DW Ross, P Sharma, HH Shah… - Kidney international, 2020 - Elsevier
The rate of acute kidney injury (AKI) associated with patients hospitalized with Covid-19, and
associated outcomes are not well understood. This study describes the presentation, risk …